Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 68 results found. Search for [ National drug pricing regulator ]

Results 1 to 21 of 68
Joe C Mathew
February 22, 2021
While the prices of four categories of medical devices - coronary stents, drug-eluting stents, condoms, and intrauterine devices - are already fixed by NPPA, the prices of the rest are fixed by the manufacturers themselves


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


PB Jayakumar
June 10, 2020
Bombay High Court has directed the Indian drug regulator National Pharmaceutical Pricing Authority (NPPA) to examine if it can cap per-year increase in N-95 masks at 10 per cent as per rules related to essential drugs


BusinessToday.In
June 4, 2020
A Gilead spokesperson told the daily that the manufacturers have been given the authority to set their own prices for the drug


BusinessToday.In
New Delhi, May 25, 2020
N-95 masks were earlier being sold in the market for Rs 150 to 300 per unit, but prices have been reduced after the advisory by the NPPA


BusinessToday.In
January 9, 2020
Share Market Update : Domestic indices gained on Thursday on back of bullish global equities after remarks by US President suggested that US and Iran were refraining from further military action.


E Kumar Sharma
New Delhi, December 31, 2019
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive


BusinessToday.In
December 16, 2019
Share Market : Key benchmark indices Sensex and Nifty turned volatile and ended lower on Monday, tracking global equities


PB Jayakumar
New Delhi, May 28, 2019
Domestic cancer drug sales are growing at 20 per cent annually for the past few years, while global growth is half of that


E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


PTI
April 1, 2019



PTI
April 1, 2019



PTI
April 1, 2019



Joe C Mathew
New Delhi, March 19, 2019
In early March, the National Pharmaceutical Pricing Authority (NPPA), India's drug price regulator, fixed the ceiling prices of 463 brands of cancer medicines.


PTI
February 27, 2019



PTI
January 23, 2019



PTI
November 2, 2018



PAGES 1 OF 4  1234